Global Biosimilar Monoclonal Antibodies Market Report 2018: Industry Analysis and Forecasts 2015-2023 - Market to Grow With a CAGR of 42.8% - ResearchAndMarkets.com

DUBLIN--()--The "Biosimilar Monoclonal Antibodies Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global biosimilar monoclonal antibodies market to grow with a CAGR of 42.8% over the forecast period of 2017-2023

The report on biosimilar monoclonal antibodies market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global biosimilar monoclonal antibodies market over the period of 2015 to 2023. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global biosimilar monoclonal antibodies market over the period of 2015 to 2023. Further, the Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Segment Covered

The global biosimilar monoclonal antibodies market is segmented on the basis of drug class and application.

Global Biosimilar Monoclonal Antibodies Market by Drug Class

  • Rituximab
  • Infliximab
  • Abciximab
  • Trastuzumab
  • Adalimumab
  • Bevacizumab

Global Biosimilar Monoclonal Antibodies Market by Application

  • Oncology
  • Chronic And Autoimmune Diseases
  • Growth Hormone Deficiency
  • Infectious Diseases
  • Others

Global Biosimilar Monoclonal Antibodies Market by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Rest of the World

Company Profiles

  • Pfizer, Inc.
  • Novartis AG
  • Reliance Life Sciences
  • Allergan plc.
  • Coherus BioSciences
  • Biocon
  • Dr. Reddy's Laboratories Ltd.
  • Boehringer Ingelheim GmbH
  • BioXpress Therapeutics SA
  • Intas Pharmaceuticals Limited
  • BIOCAD
  • Genor BioPharma Co. Ltd
  • Celltrion, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/b8nlj3/global_biosimilar?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Biopharmaceuticals, Biosimilars and Biosuperiors

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Biopharmaceuticals, Biosimilars and Biosuperiors